Reduced doses of direct oral anticoagulation are safe in atrial fibrillation patients with mild thrombocytopenia

Abstract

<p>Janion-Sadowska A, Papuga-Szela E, Łukaszuk R, Chrapek M, Undas A. Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Thrombocytopenia. <em>Journal of Cardiovascular Pharmacology</em>, 2018;72(3):153-160. doi: <a href="https://doi.org/10.1097/FJC.0000000000000607">10.1097/FJC.0000000000000607</a></p>